Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Peanut allergy: substantial disease burden in the US

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      The study was funded by DBV Technologies.

    Reference

    1. Shaker M, et al. Commercial Claims Costs Related to Healthcare Resource Use Associated With a Diagnosis of Peanut Allergy. Annals of Allergy, Asthma and Immunology : 16 Jan 2020. Available from: URL: http://doi.org/10.1016/j.anai.2020.01.004

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Peanut allergy: substantial disease burden in the US. PharmacoEcon Outcomes News 846, 20 (2020). https://doi.org/10.1007/s40274-020-6559-1

    Download citation